SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta‐analysis

Published:2021-03-21 Issue:3 Volume:8 Page:2210-2219
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Yan Yuling¹,Liu Bin¹,Du Jun¹,Wang Jing¹,Jing Xiaodong¹,Liu Yajie¹,Deng Songbai¹,Du Jianlin¹,She Qiang¹^ORCID

Affiliation:

1. Department of Cardiology The Second Affiliated Hospital of Chongqing Medical University No. 74, Linjiang Road, Yuzhong District Chongqing 400010 China

Funder

Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13313

Reference29 articles.

1. Optimal Use of Beta-Blockers for Congestive Heart Failure

2. Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis

3. Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease – Demystifying controversies

4. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure

5. Beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, nitrate-hydralazine, diuretics, aldosterone antagonist, ivabradine, devices and digoxin (BANDAID2): an evidence-based mnemonic for the treatment of systolic heart failure

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible sarcopenia and its association with hospital-associated dysphagia and decline in physical function: Findings from a heart failure patients prospective cohort study;Clinical Nutrition ESPEN;2024-10

2. The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review;Indian Heart Journal;2024-07

3. Safety and Efficacy of Dapagliflozin in Patients with Heart Failure with Reduced Ejection Fraction: Multicentre Retrospective Study on Echocardiographic Parameters and Biomarkers of Heart Congestion;Journal of Clinical Medicine;2024-06-16

4. State of the art on angiotensin-neprilysin inhibitors;Minerva Cardiology and Angiology;2024-06

5. Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction;Pharmacological Research;2024-06